Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 102084
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102084
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.102084
Table 1 Correlation between MEX3A expression and clinical parameters in hepatocellular carcinoma
Parameters | MEX3A expression | ||||
n = 26 | Low (9) | High (17) | P value | ||
Gender | Male | 24 | 8 | 16 | 1 |
Female | 2 | 1 | 1 | ||
Age (year) | < 65 | 14 | 5 | 9 | 1 |
65 | 12 | 4 | 8 | ||
TNM stage | T1, T2 | 7 | 1 | 6 | 0.3574 |
T3, T4 | 19 | 8 | 11 | ||
HBV | + | 16 | 3 | 13 | 0.0461a |
- | 10 | 6 | 4 | ||
AFP (ng/mL) | < 400 | 19 | 6 | 13 | 0.6613 |
400 | 7 | 3 | 4 | ||
Tumor diameter | < 5 | 10 | 7 | 3 | 0.0085a |
5 | 16 | 2 | 14 | ||
Differentiation | High | 9 | 6 | 3 | 0.0277a |
Low | 17 | 3 | 14 | ||
Hepatocirrhosis | + | 16 | 5 | 11 | 0.6924 |
- | 10 | 4 | 6 | ||
Vascular invasion | + | 21 | 7 | 14 | 1 |
- | 5 | 2 | 3 |
- Citation: Ji PX, Zhang P, Zhou HL, Yu H, Fu Y. MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 102084
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/102084.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.102084